Information

Related Research Units

Research Overview

Dr. Raghavan's research focuses on providing high value care and improving patient outcomes in the pediatric emergency department. Her current research interests are in the areas of diagnosis and management of children
with febrile seizures and kidney stones.

Research Background

Vidya Raghavan received her MD in Medicine from Wayne State University School of Medicine. She completed internship and residency at the University of Colorado Department of Pediatrics at Children's Hospital of Colorado. Her fellowship training was in Pediatric Emergency Medicine at Boston Children’s Hospital. Dr. Raghavan also completed the Program in Clinical Effectiveness at the Harvard School of Public Health. She joined the faculty of the Division of Emergency Medicine at Boston Children’s Hospital in 2023.

Education

Undergraduate School

Mount Holyoke College
South Hadley MA

Medical School

Wayne State University School of Medicine
Detroit MI

Residency

Pediatrics Children's Hospital Colorado/University Colorado Denver
Aurora CO

Fellowship

Emergency Medicine Boston Children's Hospital Pediatric
Boston MA

Publications

  1. Resource utilization among children presenting with cannabis poisonings in the emergency department. Am J Emerg Med. 2023 Nov; 73:171-175. View Abstract
  2. Trends in Management of Simple Febrile Seizures at US Children's Hospitals. Pediatrics. 2021 11; 148(5). View Abstract
  3. Association between secondhand marijuana smoke and respiratory infections in children. Pediatr Res. 2022 06; 91(7):1769-1774. View Abstract
  4. International Survey on the Use of Arginine Vasopressin in the Postoperative Management of Single Ventricle Patients. Front Pediatr. 2021; 9:669055. View Abstract
  5. A Randomized Double Blind Trial of Needle-free Injected Lidocaine Versus Topical Anesthesia for Infant Lumbar Puncture. Acad Emerg Med. 2018 03; 25(3):310-316. View Abstract
  6. Steady-state antigen scavenging, cross-presentation, and CD8+ T cell priming: a new role for lymphatic endothelial cells. J Immunol. 2014 Jun 01; 192(11):5002-11. View Abstract
  7. VEGF-C promotes immune tolerance in B16 melanomas and cross-presentation of tumor antigen by lymph node lymphatics. Cell Rep. 2012 Mar 29; 1(3):191-9. View Abstract

Contact Vidya Raghavan